BlackThorn Therapeutics

📍 San Francisco, United States🗓 Founded 2015👥 2 employees💰 Last funded Jul 2017
Biotechnology🌐 blackthornrx.com
Website LinkedIn
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted medicines for the treatment of central nervous system (CNS) disorders. With pathfinder™, our computational psychiatry platform, our approach is based on generating a quantitative, brain-based understanding of neurobehavioral disorders. These data-driven insights are applied to create treatments targeted to biologically-based subtypes of patients to increase the precision of therapeutic intervention. Our clinical pipeline is designed to restore balance to dysregulated brain circuits and empower individuals with CNS disorders to live better lives. BlackThorn is headquartered in San Francisco, California. For more information, please visit blackthornrx.com.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in BlackThorn Therapeutics?
BlackThorn Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did BlackThorn Therapeutics last raise funding?
The most recent investment in BlackThorn Therapeutics recorded on gritt.io was in July 2017.
When was BlackThorn Therapeutics founded?
BlackThorn Therapeutics was founded in 2015.
What industry is BlackThorn Therapeutics in?
BlackThorn Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is BlackThorn Therapeutics based?
BlackThorn Therapeutics is headquartered in San Francisco, United States.